CompoAtlas

Dexiderm AD

Natural health product licensed in Canada

Licence holder
Cipher Pharmaceuticals Inc.
NPN or DIN-HM
80068190
Status
Active licence
Licence date
1 April 2016
Revision date
29 July 2016
Form
Crème
Route of administration
Topique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
3-Pyridinecarboxamide

Source : Niacinamide

4 % (p/p)

Non-medicinal ingredients

Alcool cétostéarylique, Caprylate de glycéryle, Alcool benzylique, Cétostéaryl sulfate de sodium, Glycérol, Eau purifiée, Paraffine liquide légère

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Crème2 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in the management and relief of the signs and symptoms of atopic dermatitis (such as erythema, scaling and pruritus).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80068190

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line